ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Supernus Pharmaceuticals 

1550 East Gude Drive

Rockville  Maryland  20850  U.S.A.
Phone: 301-838-2501 Fax: n/a


SEARCH JOBS



 Key Statistics


Email:
Ownership: Public

Web Site: Supernus Pharmaceuticals
Employees:
Symbol: SUPN
 



Industry
Pharmaceutical






 Company News
Supernus Pharmaceuticals (SUPN) To Receive $30 Million In Non-Dilutive Royalty Deal 7/8/2014 7:22:29 AM
Supernus Pharmaceuticals (SUPN) To Present At Jefferies Healthcare Conference In June 5/22/2014 9:05:30 AM
Supernus Pharmaceuticals (SUPN) Receives $2 Million Milestone For United Therapeutics Corporation (UTHR)' Launch Of Orenitram™ 5/21/2014 9:32:31 AM
Supernus Pharmaceuticals (SUPN) to Host First Quarter 2014 Earnings Conference Call 4/29/2014 9:16:22 AM
Supernus Pharmaceuticals (SUPN) Announces Fourth Quarter and Full Year 2013 Results 3/13/2014 9:25:16 AM
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Third US Patent Protecting Trokendi XR™ 3/12/2014 9:32:24 AM
Supernus Pharmaceuticals (SUPN) To Host Fourth Quarter And Full Year 2013 Earnings Conference Call 2/25/2014 7:54:15 AM
Supernus Pharmaceuticals (SUPN) To Present At Cowen and Company Healthcare Conference In March 2/20/2014 7:23:01 AM
Supernus Pharmaceuticals (SUPN) At Citibank And RBC Global Healthcare Conferences In February 2/7/2014 6:45:55 AM
Supernus Pharmaceuticals (SUPN) Announces Publication Of Phase III Study (PROSPER) Results On Oxtellar XR® 2/3/2014 8:49:35 AM
1234567